Navigation Links
COCOON Disposable Paediatric - Neonatal / Child

ProductsCOCOON Disposable Paediatric - Neonatal / Child
Company Care Essentials
Item COCOON Disposable Paediatric - Neonatal / Child
Features 
  • Full surgical access as patient lies on top of quilted area
  • Two hose inlets
  • Universal inlet port ties ensure the hose remains firmly in the blanket
  • Unique microscopic pores at a rate of 65 holes per one centimetre squared
  • Single Patient Use
Description Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and fluids.
Info 

Related medicine products :

1. COCOON Convective Warming System CWS 4000
2. COCOONReusable Upper Torso Arms In
3. COCOONReusable Upper Torso Arms Out
4. COCOONReusableLower Torso
5. COCOON Disposable Upper Torso - Arms Out with face shield and tape
6. COCOONReusableUpper Torso Wedge Style
7. COCOON Disposable Lower Torso
8. COCOON Disposable Upper Torso - Arms In
9. COCOONReusable Full Torso
10. COCOON Disposable Full Torso
11. COCOON Reusable Multi Purpose
Woodson Elevator
Henner Elevator
Tenzel Double-Ended Periosteal Elevator
DesMarres Lid Retractor
Medicine Products:
(Date:12/2/2009)...2 Holly Potter, vice president, Pu...agement for Kaiser Permanente, received the "PR Te...held at the National Press Club. ,, PR News,...nnovators and professionals who day in and day out...ce. The winners of this year,s program set the ben...
(Date:12/2/2009)...., Dec. 2 From more than 1,100 pho...ning, joy and peace, the LIFE Foundation has selec...d using the popular photo-sharing Web site flickr....ontage on the LIFE Foundation,s Web site at www.l...submitted one photo and a caption to Flickr.com du...
(Date:12/2/2009)...c. 2 US Farms, Inc. (Pin..., Nursery and Wellness products, is pleased to ann...ts at the Cook,sware A,faire in Oakland, Calif., a...or additional information, contact US Farms, Inc. ...it http://cookswareafaire.com ,, Victor Brand...
(Date:12/2/2009)...., Dec. 2 Watson Pharmac... the Federal Trade Commission (FTC) has accepted a...g to Watson,s pending acquisition of privately hel... the Hart Scott Rodino waiting period, thereby per... parties have now obtained all regulatory approval...
(Date:12/2/2009)...Red Cross also part of the Hewlett-Packard Company...2 The Hewlett-Packard C...lion this year to help fund American Red Cross dis...com/cgi-bin/prnh/20090108/RedCrossLOGO ) ,, Th...p Philippine communities affected by typhoons in S...
Breaking Medicine News(10 mins):Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 3Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:US Farms, Inc. Showcasing Aloe365(TM) Product Line at Cook'sware A'faire at Oakland Zoo 2Health News:Watson Receives FTC Clearance for Arrow Acquisition 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 3
... exercisers. A new study in older adults finds tha...process by as much as 25 percent//. The faster...e infected. The results appear in a recent iss...ding to Charles Emery, a professor of psychology a...
... this may be due to genetic factors, according to ...ychiatry.// In the January issue of the journal, r...ession is higher in women than in men, where it is...depression in twins done to date. In addition, it ...
Only 75 per cent of Australian children eligible for free booster vaccine against pneumococcal disease got their shots before the program finished at the end of 2005, government figures show//. Th
...he hunting and killing of any wild birds. Turkish ...that the prohibition would continue// till Turkey ...he Eastern part of Turkey has seen two deaths due ...sis period. Agriculture and Rural Affairs Mini...
...here is a fear instilled by the disease among the ...h. But now scientist hopes that the disease can be...ermining the genes responsible to fight the diseas...ch done by the Universities of Oxford, KwaZulu-Nat...
...t and mortality rates through the launch of its ne... 72,000 babies die every year during delivery in t...iranjeevi, the government aims to bring the matern...nd births. The infant mortality rate at present is...
Other Medicine News:Health News:Wounds Heal 25% Faster In Older Adults Who Exercise Regularly 2Health News:Wounds Heal 25% Faster In Older Adults Who Exercise Regularly 3
(Date:12/2/2009)...ecember 2 Cardio Vascula...per of advanced,cardiovascular surgery technology,...tors approved a one-for-three forward stock split,...o Vascular Medical Device shareholders. , ...ated date the stock,split will be payable and the ...
(Date:12/2/2009)...2 Roche (SIX: RO, ROG; O...s Food & Drug Administration (FDA) approved an...acid test, to screen source plasma in pools compri...lled the cobas® TaqScreen MPX Test for use on...tro test for the simultaneous, direct detection of...
(Date:12/2/2009)...., Dec. 2 Novartis announced today...tion on Tasigna® (nilotinib) 200 mg capsules ... the strength of the company,s hematology portfoli...w data, at the 51st American Society of Hematology...e company,s current therapies and investigational ...
Breaking Medicine Technology:Cardio Vascular Medical Device Announces Forward Stock Split 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25American Medical Informatics Association 28AMIA 29 Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certifi 13045 1American Medical Informatics Association 28AMIA 29 Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certifi 13045 2National Coalition of Mental Health Consumer Survivor Organizations Hires Director of Government Relations 51792 1National Coalition of Mental Health Consumer Survivor Organizations Hires Director of Government Relations 51792 2Proposed Water Trust Fund Bill Would Provide Solid Foundation for Improvement 51788 1Proposed Water Trust Fund Bill Would Provide Solid Foundation for Improvement 51788 2